Timothy L Gibbons, OD | |
1492 W Antelope Dr Ste 150, Layton, UT 84041-1137 | |
(801) 776-7804 | |
Not Available |
Full Name | Timothy L Gibbons |
---|---|
Gender | Male |
Speciality | Optometry |
Experience | 20 Years |
Location | 1492 W Antelope Dr Ste 150, Layton, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700967593 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 5695589-9934 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Utah Hospitals And Clinics | Salt lake city, UT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Utah Adult Services | 0941525273 | 1459 |
News Archive
Patients with acute heart failure nearly double their risk of dying if they get COVID-19, according to research published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).
An international research team has compiled the first catalogue of tissue-specific pathologies underlying hundreds of inherited diseases.
The U.S. Food and Drug Administration today approved Evrysdi (risdiplam) to treat patients two months of age and older with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.
Despite a 2011 pledge among United States chain restaurants to improve the nutritional value of children's menu options, a new study finds no significant improvements have been made to cut calories, saturated fat, or sodium.
› Verified 6 days ago
Provider Name | University Of Utah |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1588656870 PECOS PAC ID: 0749262665 Enrollment ID: O20050629000441 |
News Archive
Patients with acute heart failure nearly double their risk of dying if they get COVID-19, according to research published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).
An international research team has compiled the first catalogue of tissue-specific pathologies underlying hundreds of inherited diseases.
The U.S. Food and Drug Administration today approved Evrysdi (risdiplam) to treat patients two months of age and older with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.
Despite a 2011 pledge among United States chain restaurants to improve the nutritional value of children's menu options, a new study finds no significant improvements have been made to cut calories, saturated fat, or sodium.
› Verified 6 days ago
Provider Name | University Of Utah Community Physicians Group |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1598169203 PECOS PAC ID: 9739403569 Enrollment ID: O20150126002118 |
News Archive
Patients with acute heart failure nearly double their risk of dying if they get COVID-19, according to research published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).
An international research team has compiled the first catalogue of tissue-specific pathologies underlying hundreds of inherited diseases.
The U.S. Food and Drug Administration today approved Evrysdi (risdiplam) to treat patients two months of age and older with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.
Despite a 2011 pledge among United States chain restaurants to improve the nutritional value of children's menu options, a new study finds no significant improvements have been made to cut calories, saturated fat, or sodium.
› Verified 6 days ago
Provider Name | University Of Utah Adult Services |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
Patients with acute heart failure nearly double their risk of dying if they get COVID-19, according to research published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).
An international research team has compiled the first catalogue of tissue-specific pathologies underlying hundreds of inherited diseases.
The U.S. Food and Drug Administration today approved Evrysdi (risdiplam) to treat patients two months of age and older with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.
Despite a 2011 pledge among United States chain restaurants to improve the nutritional value of children's menu options, a new study finds no significant improvements have been made to cut calories, saturated fat, or sodium.
› Verified 6 days ago
Provider Name | University Of Utah Pediatric Services |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1487018974 PECOS PAC ID: 0547552473 Enrollment ID: O20160713000371 |
News Archive
Patients with acute heart failure nearly double their risk of dying if they get COVID-19, according to research published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).
An international research team has compiled the first catalogue of tissue-specific pathologies underlying hundreds of inherited diseases.
The U.S. Food and Drug Administration today approved Evrysdi (risdiplam) to treat patients two months of age and older with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.
Despite a 2011 pledge among United States chain restaurants to improve the nutritional value of children's menu options, a new study finds no significant improvements have been made to cut calories, saturated fat, or sodium.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Timothy L Gibbons, OD Po Box 510708, Salt Lake City, UT 84151-0708 Ph: (801) 213-3900 | Timothy L Gibbons, OD 1492 W Antelope Dr Ste 150, Layton, UT 84041-1137 Ph: (801) 776-7804 |
News Archive
Patients with acute heart failure nearly double their risk of dying if they get COVID-19, according to research published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).
An international research team has compiled the first catalogue of tissue-specific pathologies underlying hundreds of inherited diseases.
The U.S. Food and Drug Administration today approved Evrysdi (risdiplam) to treat patients two months of age and older with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.
Despite a 2011 pledge among United States chain restaurants to improve the nutritional value of children's menu options, a new study finds no significant improvements have been made to cut calories, saturated fat, or sodium.
› Verified 6 days ago
Franklin R Knowlton Od Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 195 E Gentile St, Suite #3, Layton, UT 84041 Phone: 801-546-2020 Fax: 801-546-1237 | |
Kyle D Wilson Od Pc Optometrist Medicare: Medicare Enrolled Practice Location: 489 W 2275 N Ste B, Layton, UT 84041 Phone: 801-776-2020 | |
Mr. Franklin R Knowlton, OD,PLLC Optometrist Medicare: Not Enrolled in Medicare Practice Location: 195 E Gentile St, Suite 3, Layton, UT 84041 Phone: 801-546-2020 Fax: 801-546-1237 | |
Dr Larsen Eye Care Inc Optometrist Medicare: Medicare Enrolled Practice Location: 815 W 2000 N, Layton, UT 84041 Phone: 801-776-4426 Fax: 801-776-4437 | |
Uuhc Davis Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1492 W Antelope Dr, Ste. 150, Layton, UT 84041 Phone: 801-776-7804 | |
Dr. Brian Paul Johnson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 745 W Hill Field Rd, Layton, UT 84041 Phone: 801-546-4759 Fax: 801-546-1240 | |
Russell Purdy, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1076 Layton Hills Mall Ste 2090, Layton, UT 84041 Phone: 801-546-0255 Fax: 801-546-0260 |